CRESCENT BIOPHARMA INC (CBIO) Earnings History & Surprises
NASDAQ:CBIO • KYG2545C1042
11.275 USD
-0.21 (-1.87%)
Last: Mar 5, 2026, 02:30 PM
Past quarterly earnings results for CRESCENT BIOPHARMA INC (CBIO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateN/A
PeriodQ4 / 2025
EPS Estimate-$2.57
Revenue Estimate3.4M
Last Reported
Release DateFeb 16, 2026
PeriodQ3 / 2025
EPS Reported-$1.27
EPS Surprise 37.18%
Revenue Surprise %
Beat Rate
0%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -1.27 | -2.02 | 37.18% | -1,031.91% | - | - | ||
| Q2 2025 | -4.93 | -1.80 | -174.23% | 69.19% | - | - | ||
| Q1 2025 | -4.00 | -5.10 | 21.57% | 76.47% | - | - | ||
| Q4 2024 | -0.16 | - | 98.83% | - | -100.00% | |||
| Q3 2024 | -0.11 | - | 99.20% | - | - | |||
| Q2 2024 | -16.00 | -17.09 | 6.35% | -23.08% | - | - | ||
| Q1 2024 | -17.00 | -16.83 | -1.01% | - | - | - | ||
| Q4 2023 | -14.00 | -15.56 | 10.00% | 26.32% | 10K | - | - | |
| Q3 2023 | -14.00 | -14.62 | 4.24% | 12.50% | - | - | ||
| Q2 2023 | -13.00 | -18.70 | 30.48% | 48.00% | - | -100.00% | ||
| Q1 2023 | -17.00 | -17.00 | 0.00% | 39.29% | - | - | ||
| Q4 2022 | -19.00 | -17.00 | -11.76% | 42.42% | - | -100.00% | ||
| Q3 2022 | -16.00 | -26.86 | 40.43% | 52.94% | - | -100.00% | ||
| Q2 2022 | -25.00 | -29.07 | 14.00% | 10.71% | 80K | - | - | |
| Q1 2022 | -28.00 | -31.28 | 10.49% | - | - | -100.00% | ||
| Q4 2021 | -33.00 | -34.43 | 4.14% | -3.13% | 20K | - | -87.50% | |
| Q3 2021 | -34.00 | -32.39 | -4.99% | -17.24% | 90K | - | -91.00% | |
| Q2 2021 | -28.00 | -31.37 | 10.73% | 12.50% | - | - | ||
| Q1 2021 | -28.00 | -32.44 | 13.68% | -55.56% | 1.06M | - | -88.22% | |
| Q4 2020 | -32.00 | -32.84 | 2.57% | - | 160K | 204K | -21.57% | - |
| Q3 2020 | -29.00 | -33.46 | 13.32% | - | 1M | - | - | |
| Q2 2020 | -32.00 | -38.76 | 17.44% | - | - | - | ||
| Q1 2020 | -18.00 | -31.01 | 41.95% | - | 9M | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
CRESCENT BIOPHARMA INC / CBIO Earnings FAQ
Can you provide the last earnings date for CRESCENT BIOPHARMA INC?
CRESCENT BIOPHARMA INC (CBIO) last reported earnings on 2/16/2026.
Did CBIO stock beat earnings estimates in the most recent quarter?
CRESCENT BIOPHARMA INC (CBIO) beat EPS estimates and missed revenue estimates in the most recent quarter.